• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人神经遗传性疾病的诊断概况

The Diagnostic Landscape of Adult Neurogenetic Disorders.

作者信息

Waung Maggie W, Ma Fion, Wheeler Allison G, Zai Clement C, So Joyce

机构信息

Division of General Neurology, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, CA 94158, USA.

Institute for Human Genetics, University of California San Francisco School of Medicine, San Francisco, CA 94143, USA.

出版信息

Biology (Basel). 2023 Nov 22;12(12):1459. doi: 10.3390/biology12121459.

DOI:10.3390/biology12121459
PMID:38132285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10740572/
Abstract

Neurogenetic diseases affect individuals across the lifespan, but accurate diagnosis remains elusive for many patients. Adults with neurogenetic disorders often undergo a long diagnostic odyssey, with multiple specialist evaluations and countless investigations without a satisfactory diagnostic outcome. Reasons for these diagnostic challenges include: (1) clinical features of neurogenetic syndromes are diverse and under-recognized, particularly those of adult-onset, (2) neurogenetic syndromes may manifest with symptoms that span multiple neurological and medical subspecialties, and (3) a positive family history may not be present or readily apparent. Furthermore, there is a large gap in the understanding of how to apply genetic diagnostic tools in adult patients, as most of the published literature focuses on the pediatric population. Despite these challenges, accurate genetic diagnosis is imperative to provide affected individuals and their families guidance on prognosis, recurrence risk, and, for an increasing number of disorders, offer targeted treatment. Here, we provide a framework for recognizing adult neurogenetic syndromes, describe the current diagnostic approach, and highlight studies using next-generation sequencing in different neurological disease cohorts. We also discuss diagnostic pitfalls, barriers to achieving a definitive diagnosis, and emerging technology that may increase the diagnostic yield of testing.

摘要

神经遗传疾病影响着各个年龄段的个体,但对许多患者来说,准确诊断仍然难以实现。患有神经遗传疾病的成年人往往要经历漫长的诊断过程,接受多次专科评估和无数项检查,却得不到令人满意的诊断结果。这些诊断难题的原因包括:(1)神经遗传综合征的临床特征多种多样且未得到充分认识,尤其是成人发病型;(2)神经遗传综合征可能表现出跨越多个神经科和医学亚专科的症状;(3)可能没有阳性家族史或家族史不明显。此外,在如何将基因诊断工具应用于成年患者方面,人们的认识存在很大差距,因为大多数已发表的文献都集中在儿科人群。尽管存在这些挑战,但准确的基因诊断对于为受影响的个体及其家庭提供预后、复发风险指导以及针对越来越多的疾病提供靶向治疗至关重要。在此,我们提供一个识别成人神经遗传综合征的框架,描述当前的诊断方法,并强调在不同神经疾病队列中使用下一代测序的研究。我们还将讨论诊断陷阱、实现明确诊断的障碍以及可能提高检测诊断率的新兴技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b43c/10740572/dd8bed5ee68b/biology-12-01459-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b43c/10740572/dd8bed5ee68b/biology-12-01459-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b43c/10740572/dd8bed5ee68b/biology-12-01459-g001.jpg

相似文献

1
The Diagnostic Landscape of Adult Neurogenetic Disorders.成人神经遗传性疾病的诊断概况
Biology (Basel). 2023 Nov 22;12(12):1459. doi: 10.3390/biology12121459.
2
The odyssey of complex neurogenetic disorders: From undetermined to positive.复杂神经遗传疾病的探索之旅:从不确定到确定。
Am J Med Genet C Semin Med Genet. 2020 Dec;184(4):876-884. doi: 10.1002/ajmg.c.31848. Epub 2020 Oct 20.
3
Assessment of whole-exome sequencing results in neurogenetic diseases.神经遗传疾病全外显子测序结果评估。
J Hum Genet. 2023 Dec;68(12):797-804. doi: 10.1038/s10038-023-01185-7. Epub 2023 Jul 31.
4
Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach.神经遗传学探索中的全外显子组测序:一种有效、节省成本和时间的诊断方法。
PLoS One. 2018 Feb 1;13(2):e0191228. doi: 10.1371/journal.pone.0191228. eCollection 2018.
5
Effect of Whole Exome Sequencing in Diagnosis of Inborn Errors of Metabolism and Neurogenetic Disorders.全外显子测序在先天性代谢缺陷和神经遗传性疾病诊断中的作用
Iran J Child Neurol. 2018 Winter;12(1):7-15.
6
Improving the efficacy of exome sequencing at a quaternary care referral centre: novel mutations, clinical presentations and diagnostic challenges in rare neurogenetic diseases.提高四级医疗转诊中心外显子组测序的疗效:罕见神经遗传疾病中的新突变、临床表现和诊断挑战。
J Neurol Neurosurg Psychiatry. 2021 Nov;92(11):1186-1196. doi: 10.1136/jnnp-2020-325437. Epub 2021 Jun 8.
7
Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test.重度神经发育障碍的诊断历程:迈向将临床全外显子测序作为一线诊断测试
Clin Genet. 2016 Jun;89(6):700-7. doi: 10.1111/cge.12732. Epub 2016 Apr 26.
8
Next-Generation Sequencing Technologies and Neurogenetic Diseases.下一代测序技术与神经遗传性疾病
Life (Basel). 2021 Apr 19;11(4):361. doi: 10.3390/life11040361.
9
Identification of the genetic basis of pediatric neurogenetic disorders at a tertiary referral hospital in Indonesia: Contribution of whole exome sequencing.印度尼西亚一家三级转诊医院儿科神经遗传疾病的遗传基础鉴定:全外显子组测序的贡献。
PLoS One. 2023 Oct 25;18(10):e0293113. doi: 10.1371/journal.pone.0293113. eCollection 2023.
10
Genomic medicine and risk prediction across the disease spectrum.基因组医学与疾病谱中的风险预测。
Crit Rev Clin Lab Sci. 2015;52(3):120-37. doi: 10.3109/10408363.2014.997930. Epub 2015 Jan 19.

引用本文的文献

1
Update on Inherited Pediatric Motor Neuron Diseases: Clinical Features and Outcome.小儿遗传性运动神经元病的研究进展:临床特征与预后
Genes (Basel). 2024 Oct 21;15(10):1346. doi: 10.3390/genes15101346.

本文引用的文献

1
Patient Travel Distance to Neurologist Visits.患者前往神经科医生处就诊的行程距离。
Neurology. 2023 Oct 31;101(18):e1807-e1820. doi: 10.1212/WNL.0000000000207810. Epub 2023 Sep 13.
2
Inherited metabolic disorders in adults: systematic review on patient characteristics and diagnostic yield of broad sequencing techniques (exome and genome sequencing).成人遗传性代谢紊乱:关于患者特征及广泛测序技术(外显子组和基因组测序)诊断率的系统评价
Front Neurol. 2023 Jul 25;14:1206106. doi: 10.3389/fneur.2023.1206106. eCollection 2023.
3
ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
ACMG SF v3.2 临床外显子组和基因组测序中报告次要发现的列表:美国医学遗传学与基因组学学会 (ACMG) 的政策声明。
Genet Med. 2023 Aug;25(8):100866. doi: 10.1016/j.gim.2023.100866. Epub 2023 Jun 22.
4
Meta-analysis of the diagnostic and clinical utility of exome and genome sequencing in pediatric and adult patients with rare diseases across diverse populations.对在不同人群中患有罕见病的儿科和成年患者进行外显子组和基因组测序的诊断和临床效用的荟萃分析。
Genet Med. 2023 Sep;25(9):100896. doi: 10.1016/j.gim.2023.100896. Epub 2023 May 13.
5
Exome Sequencing and Multigene Panel Testing in 1,411 Patients With Adult-Onset Neurologic Disorders.1411例成人起病神经系统疾病患者的外显子组测序和多基因检测板检测
Neurol Genet. 2023 Apr 26;9(3):e200071. doi: 10.1212/NXG.0000000000200071. eCollection 2023 Jun.
6
Stepwise use of genomics and transcriptomics technologies increases diagnostic yield in Mendelian disorders.逐步使用基因组学和转录组学技术可提高孟德尔疾病的诊断率。
Front Cell Dev Biol. 2023 Feb 28;11:1021920. doi: 10.3389/fcell.2023.1021920. eCollection 2023.
7
The phenotypic and genotypic spectrum of epilepsy and intellectual disability in adults: Implications for genetic testing.成人癫痫和智力障碍的表型和基因型谱:对基因检测的影响。
Epilepsia Open. 2023 Jun;8(2):497-508. doi: 10.1002/epi4.12719. Epub 2023 Mar 17.
8
Predictors of the utility of clinical exome sequencing as a first-tier genetic test in patients with Mendelian phenotypes: results from a referral center study on 603 consecutive cases.作为一线基因检测手段,临床外显子组测序在孟德尔表型患者中的效用预测因素:来自一个转诊中心的 603 例连续病例研究结果。
Hum Genomics. 2023 Feb 5;17(1):5. doi: 10.1186/s40246-023-00455-x.
9
Genetic Causes of Cerebral Small Vessel Diseases: A Practical Guide for Neurologists.脑小血管病的遗传学病因:神经病学家实用指南。
Neurology. 2023 Apr 18;100(16):766-783. doi: 10.1212/WNL.0000000000201720. Epub 2022 Dec 19.
10
Deep Intronic GAA Repeat Expansion in Late-Onset Cerebellar Ataxia.迟发性小脑共济失调中的深度内含子 GAA 重复扩展。
N Engl J Med. 2023 Jan 12;388(2):128-141. doi: 10.1056/NEJMoa2207406. Epub 2022 Dec 14.